3 U.S. lawmakers have disclosed 4 Fresenius Medical Care AG trades under the STOCK Act — 1 buy and 3 sells between 2018 and 2026. Congress has been net sellers of FMCQF, and their disclosed buys are up 16.3% versus the latest close.
*Notional-weighted price return on lawmakers' disclosed buys of FMCQF, marked to the latest close — per-share (share counts aren't disclosed).
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2026-03-30 | Alan Armstrong | BUY | $1K–$15K | $44.25 | $51.44 2026-08-28 | +16.3% |
| 2019-01-02 | Greg Gianforte | SELL | $100K–$250K | $64.56 | $51.44 2026-08-28 | +20.3% exit |
| 2018-12-21 | Josh Gottheimer | SELL | $1K–$15K | $63.10 | $51.44 2026-08-28 | +18.5% exit |
| 2018-07-05 | Greg Gianforte | SELL | $15K–$50K | $100.97 | $51.44 2026-08-28 | +49.0% exit |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
3 members of the U.S. House and Senate have disclosed Fresenius Medical Care AG transactions under the STOCK Act — 1 purchase and 3 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a FMCQF purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Notional-weighted, lawmakers' disclosed FMCQF buys are up 16.3% versus the latest close of $51.44. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded FMCQF and how it performed.